Full Transcript: Lindsay Avner, Founder and CEO of Bright Pink, on Sequenced
On this episode of Sequenced, we talk to Lindsay Avner, Founder and CEO of Bright Pink. Lindsay underwent genetic testing at age 22. The test revealed she carried a mutation on the BRCA1 gene. At 23, she became the youngest woman in the U.S. to undergo a risk-reducing double mastectomy. Lindsay shares her commitment to live proactively, why she founded Bright Pink, and how women can be advocates for their own health.
Bright Pink is a national non-profit organization that focuses on saving women’s lives from breast and ovarian cancer by empowering them to live proactively at a young age. Bright Pink offers interactive digital tools to help women assess their risk for breast and ovarian cancer (assessyourrisk.org) and address their questions around genetic testing (exploreyourgenetics.org).Tags: Breast Cancer, Cancer, Genetics, Health, Podcast